NRG Oncology received a five-year funding award in fall 2014 to carry out clinical research as a National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base. The NRG NCORP Research Base will provide scientific and statistical leadership for developing, implementing, and analyzing multi-institutional clinical trials of cancer prevention, control, screening, and post treatment surveillance, as well as cancer care delivery research (CCDR).
NRG NCORP research plans are well integrated into NRG Oncology’s scientific program, which includes a unique focus on both women’s health and radiation therapy. The overarching research themes the NRG NCORP plans to pursue include:
- Developing cancer prevention and symptom intervention trials in which biomarker status determines eligibility and/or treatment response
- Testing and further validating patient-reported measures across many cancer disease types to evaluate and design interventions to improve the quality of life of cancer survivors
- Improving early detection and diagnostic techniques that avoid overdiagnosis and underdiagnosis of cancers
- Leveraging NRG Oncology’s therapeutic trials to provide a unique research portfolio—with particular foci on women’s cancers and radiation oncology innovation—to NRG Oncology’s research community and across the National Clinical Trials Network (NCTN)
- Reducing disparities in cancer care outcomes among minority and underserved populations